Campbell & Co Investment Adviser’s Axogen AXGN Stock Holding History

Campbell & Co Investment Adviser’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,637	Closed	-$192K	–	1027
2024 Q4	$192K	Buy	+11,637	New	+$165K	0.01%	979
2023 Q3	–	Sell	-14,325	Closed	-$131K	–	941
2023 Q2	$131K	Buy	+14,325	New	+$134K	0.02%	832
2022 Q1	–	Sell	-32,600	Closed	-$305K	–	697
2021 Q4	$305K	Buy	+32,600	New	+$391K	0.1%	353
2018 Q3	–	Sell	-4,434	Closed	-$223K	–	398
2018 Q2	$223K	Buy	+4,434	New	+$195K	0.17%	278
2018 Q1	–	Sell	-13,585	Closed	-$384K	–	361
2017 Q4	$384K	Sell	13,585 -24,376	-64%	-$575K	0.28%	114
2017 Q3	$735K	Buy	37,961 +18,166	+92%	+$305K	0.59%	29
2017 Q2	$332K	Buy	19,795 +8,740	+79%	+$118K	0.31%	109
2017 Q1	$116K	Buy	11,055 +341	+3%	+$3.48K	0.3%	135
2016 Q4	$96K	Buy	+10,714	New	+$92.3K	0.3%	122

Other funds holding AXGN

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Campbell & Co Investment Adviser's AXGN Position: Q1 2025 in Review

Campbell & Co Investment Adviser sold out of Axogen (AXGN) in Q1 2025, closing a stake of 11,637 shares — an estimated $192K sold.

Campbell & Co Investment Adviser first reported a position in AXGN in Q4 2016 and held it in 9 quarters. The position peaked at $735K in Q3 2017. 181 funds tracked by Wall St. Rank hold AXGN as of Q1 2025.

Campbell & Co Investment Adviser reported no remaining Axogen position as of Q1 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 11,637 Axogen shares in Q1 2025, an estimated $192K.
Campbell & Co Investment Adviser first reported a position in Axogen in Q4 2016 and held it in 9 quarters.
Campbell & Co Investment Adviser's Axogen position peaked at $735K in Q3 2017.
181 funds tracked by Wall St. Rank held Axogen as of Q1 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.